| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Adamas Pharmaceuticals (ADMS) | Credit Suisse/ Piper Jaffray | $69.00 | n.a. | |||
| Biomet Group (BMET) | BofA Merrill Lynch/ Goldman Sachs/ J.P. Morgan | $100.00 | n.a. | |||
| Corium International (CORI) | Jefferies/ Leerink Partners | $50.00 | n.a. | |||
| Dorian LPG (LPG) | J.P. Morgan/ UBS Investment Bank | $287.50 | n.a. | |||
| Five9 (FIVN) | J.P. Morgan/ Barclays/ BofA Merrill Lynch | $100.00 | n.a. | |||
| iKang Healthcare Group (KANG) | BofA Merrill Lynch/ UBS Investment Bank | $150.00 | n.a. | |||
| Moelis (MC) | Goldman Sachs/ Morgan Stanley/ Moelis & Company | $100.00 | n.a. | |||
| Opower (OPWR) | Morgan Stanley/ Goldman Sachs | $100.00 | n.a. | |||
| Quotient (QTNT) | UBS Investment Bank/ Baird/ Cowen | $75.00 | n.a. | |||
| Sportsmans Warehouse Holdings (SPWH) | Credit Suisse/ Goldman Sachs | $201.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Akebia Therapeutics (AKBA) | Morgan Stanley/ Credit Suisse/ UBS Investment Bank | 4.90 | $14.00 | $17.00 | $75.95 | n.a. |
| Amber Road (AMBR) | Stifel | 6.52 | $10.50 | $12.50 | $75.01 | n.a. |
| Applied Genetic Technologies (AGTC) | BMO Capital Markets/ Wedbush PacGrow Life Sciences | $70.00 | n.a. | |||
| Castlight Health (CSLT) | Goldman Sachs/ Morgan Stanley | 11.10 | $9.00 | $11.00 | $111.00 | 3-Stars |
| City Office REIT (CIO) | Janney Montgomery Scott/ Wunderlich Securities/ Oppenheimer | $115.00 | n.a. | |||
| MediWound Ltd. (MDWD) | Credit Suisse/ Jefferies/ BMO Capital Markets | 5.00 | $14.00 | $16.00 | $75.00 | n.a. |
| Paylocity Holding (PCTY) | Deutsche Bank Securities/ BofA Merrill Lynch/ William Blair | 6.67 | $14.00 | $16.00 | $100.05 | n.a. |
| Q2 Holdings (QTWO) | J.P. Morgan/ Stifel | 7.76 | $11.00 | $13.00 | $93.13 | n.a. |
| Versartis (VSAR) | Morgan Stanley/ Citigroup | $80.00 | n.a. | |||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of March 3, 2014 | Manager(s) | Offered | Raised | Price | 3/7/14 | Change |
| COUPONS.com ( COUP) | Goldman Sachs/ Allen & Company/ BofA Merrill Lynch/ RBC Capital Markets | 10.50 | $168.00 | $16.00 | $30.00 | 87.50% |
| Aquinox Pharmaceuticals (AQXP) | Jefferies/ Cowen and Company | 4.20 | $46.20 | $11.00 | $11.95 | 8.64% |
| Recro Pharma (REPH) | Aegis Capital Corp | 3.75 | $30.00 | $8.00 | $8.30 | 3.75% |
| TriplePoint Venture Growth BDC (TPVG) | Morgan Stanley/ Wells Fargo Securities/ Goldman Sachs/ Credit Suisse/ UBS Investment Bank | 8.32 | $124.83 | $15.00 | $15.55 | 3.67% |
